Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
28 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

Science


RSS FeedsTG Therapeutics Is Worth A Look Before Phase 3 Combination Cancer Data
(WorldNews Health)

 
 

18 august 2018 11:10:31

 
TG Therapeutics Is Worth A Look Before Phase 3 Combination Cancer Data
(WorldNews Health)
 


TG Therapeutics (NASDAQ:TGTX) might be worth a speculative buy because it will release data from its phase 3 cancer study, which is approaching quickly. If the results are positive, then it will be able to file for an FDA approval of its combination product TG-1101 (ublituximab) and TGR-1202 (umbralisib) to treat patients with first-line relapsed or refractory chronic lymphocytic leukemia (CLL). That would be a good opportunity for the company to finally achieve FDA approval for a product in its pipeline. Phase 3 Combination Study The phase 3 study is recruiting up to 600 patients who are treatment naive and have relapsed or refractory CLL. Patients in the study are either going to take...


 
9 viewsCategory: Science > Medicine
 
Ease Back-to-School Stress: Stop Procrastinating 101
(WorldNews Health)
Mali`s opposition leader Soumaila Cissé rejects presidential runoff result
(WorldNews Health)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten